Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination.

Garcés JJ, Simicek M, Vicari M, Brozova L, Burgos L, Bezdekova R, Alignani D, Calasanz MJ, Growkova K, Goicoechea I, Agirre X, Pour L, Prosper F, Rios R, Martinez-Lopez J, Millacoy P, Palomera L, Del Orbe R, Perez-Montaña A, Garate S, Blanco L, Lasa M, Maiso P, Flores-Montero J, Sanoja-Flores L, Chyra Z, Vdovin A, Sevcikova T, Jelinek T, Botta C, El Omri H, Keats J, Orfao A, Hajek R, San-Miguel JF, Paiva B.

Leukemia. 2019 Oct 8. doi: 10.1038/s41375-019-0588-4. [Epub ahead of print]

PMID:
31595039
2.

The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma.

Moreno L, Perez C, Zabaleta A, Manrique I, Alignani D, Ajona D, Blanco L, Lasa M, Maiso P, Rodriguez I, Garate S, Jelinek T, Segura V, Moreno C, Merino J, Rodriguez-Otero P, Panizo C, Prosper F, San-Miguel JF, Paiva B.

Clin Cancer Res. 2019 May 15;25(10):3176-3187. doi: 10.1158/1078-0432.CCR-18-1597. Epub 2019 Jan 28.

PMID:
30692097
3.

Resveratrol promotes apoptosis through the induction of dual specificity phosphatase 1 and sensitizes prostate cancer cells to cisplatin.

Martínez-Martínez D, Soto A, Gil-Araujo B, Gallego B, Chiloeches A, Lasa M.

Food Chem Toxicol. 2019 Feb;124:273-279. doi: 10.1016/j.fct.2018.12.014. Epub 2018 Dec 12.

PMID:
30552915
4.

Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis.

Puig N, Paiva B, Lasa M, Burgos L, Perez JJ, Merino J, Moreno C, Vidriales MB, Toboso DG, Cedena MT, Ocio EM, Lecumberri R, García de Coca A, Labrador J, Gonzalez ME, Palomera L, Gironella M, Cabañas V, Casanova M, Oriol A, Krsnik I, Pérez-Montaña A, de la Rubia J, de la Puerta JE, de Arriba F, Prosper F, Martinez-Lopez J, Lecrevisse Q, Verde J, Mateos MV, Lahuerta JJ, Orfao A, San Miguel JF.

Leukemia. 2019 May;33(5):1256-1267. doi: 10.1038/s41375-018-0308-5. Epub 2018 Dec 12.

PMID:
30542145
5.

Author Correction: Excitotoxic inactivation of constitutive oxidative stress detoxification pathway in neurons can be rescued by PKD1.

Pose-Utrilla J, García-Guerra L, Del Puerto A, Martín A, Jurado-Arjona J, De León-Reyes NS, Gamir-Morralla A, Sebastián-Serrano Á, García-Gallo M, Kremer L, Fielitz J, Ireson C, Pérez-Álvarez MJ, Ferrer I, Hernández F, Ávila J, Lasa M, Campanero MR, Iglesias T.

Nat Commun. 2018 Jan 30;9(1):473. doi: 10.1038/s41467-018-03022-4.

6.

Excitotoxic inactivation of constitutive oxidative stress detoxification pathway in neurons can be rescued by PKD1.

Pose-Utrilla J, García-Guerra L, Del Puerto A, Martín A, Jurado-Arjona J, De León-Reyes NS, Gamir-Morralla A, Sebastián-Serrano Á, García-Gallo M, Kremer L, Fielitz J, Ireson C, Pérez-Álvarez MJ, Ferrer I, Hernández F, Ávila J, Lasa M, Campanero MR, Iglesias T.

Nat Commun. 2017 Dec 22;8(1):2275. doi: 10.1038/s41467-017-02322-5. Erratum in: Nat Commun. 2018 Jan 30;9(1):473.

7.

NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma.

Neri L, Lasa M, Elosegui-Artola A, D'Avola D, Carte B, Gazquez C, Alve S, Roca-Cusachs P, Iñarrairaegui M, Herrero J, Prieto J, Sangro B, Aldabe R.

Oncotarget. 2017 Jun 20;8(25):40967-40981. doi: 10.18632/oncotarget.17332.

8.

VHL promotes immune response against renal cell carcinoma via NF-κB-dependent regulation of VCAM-1.

Labrousse-Arias D, Martínez-Alonso E, Corral-Escariz M, Bienes-Martínez R, Berridy J, Serrano-Oviedo L, Conde E, García-Bermejo ML, Giménez-Bachs JM, Salinas-Sánchez AS, Sánchez-Prieto R, Yao M, Lasa M, Calzada MJ.

J Cell Biol. 2017 Mar 6;216(3):835-847. doi: 10.1083/jcb.201608024. Epub 2017 Feb 24.

9.

Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis.

Paiva B, Martinez-Lopez J, Corchete LA, Sanchez-Vega B, Rapado I, Puig N, Barrio S, Sanchez ML, Alignani D, Lasa M, García de Coca A, Pardal E, Oriol A, Garcia ME, Escalante F, González-López TJ, Palomera L, Alonso J, Prosper F, Orfao A, Vidriales MB, Mateos MV, Lahuerta JJ, Gutierrez NC, San Miguel JF.

Blood. 2016 Jun 16;127(24):3035-9. doi: 10.1182/blood-2015-10-673095. Epub 2016 Apr 11.

PMID:
27069257
10.

TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways.

Baquero P, Jiménez-Mora E, Santos A, Lasa M, Chiloeches A.

Mol Carcinog. 2016 Nov;55(11):1639-1654. doi: 10.1002/mc.22415. Epub 2015 Sep 21.

PMID:
26392228
11.

Geodesic Binding for Degenerate Character Geometry Using Sparse Voxelization.

Dionne O, de Lasa M.

IEEE Trans Vis Comput Graph. 2014 Oct;20(10):1367-78. doi: 10.1109/TVCG.2014.2321563.

PMID:
26357384
12.

Hepatitis C virus-mediated Aurora B kinase inhibition modulates inflammatory pathway and viral infectivity.

Madejón A, Sheldon J, Francisco-Recuero I, Perales C, Domínguez-Beato M, Lasa M, Sánchez-Perez I, Muntané J, Domingo E, García-Samaniego J, Sánchez-Pacheco A.

J Hepatol. 2015 Aug;63(2):312-9. doi: 10.1016/j.jhep.2015.02.036. Epub 2015 Feb 27.

PMID:
25733156
13.

Image analysis for the quantitative comparison of stress fibers and focal adhesions.

Elosegui-Artola A, Jorge-Peñas A, Moreno-Arotzena O, Oregi A, Lasa M, García-Aznar JM, De Juan-Pardo EM, Aldabe R.

PLoS One. 2014 Sep 30;9(9):e107393. doi: 10.1371/journal.pone.0107393. eCollection 2014.

14.

Dual specificity phosphatase 1 expression inversely correlates with NF-κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism.

Gil-Araujo B, Toledo Lobo MV, Gutiérrez-Salmerón M, Gutiérrez-Pitalúa J, Ropero S, Angulo JC, Chiloeches A, Lasa M.

Mol Oncol. 2014 Feb;8(1):27-38. doi: 10.1016/j.molonc.2013.08.012. Epub 2013 Sep 14.

15.

Trajectory optimization for full-body movements with complex contacts.

Al Borno M, de Lasa M, Hertzmann A.

IEEE Trans Vis Comput Graph. 2013 Aug;19(8):1405-14. doi: 10.1109/TVCG.2012.325.

PMID:
23744269
16.

The use of an active learning approach to teach metabolism to students of nutrition and dietetics.

González-Sancho JM, Sánchez-Pacheco A, Lasa M, Molina S, Vara F, del Peso L.

Biochem Mol Biol Educ. 2013 May-Jun;41(3):131-8. doi: 10.1002/bmb.20684. Epub 2013 Mar 9.

17.

Balance between apoptosis or survival induced by changes in extracellular-matrix composition in human mesangial cells: a key role for ILK-NFκB pathway.

del Nogal M, Luengo A, Olmos G, Lasa M, Rodriguez-Puyol D, Rodriguez-Puyol M, Calleros L.

Apoptosis. 2012 Dec;17(12):1261-74. doi: 10.1007/s10495-012-0769-3.

PMID:
23054083
18.

N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.

Van Damme P, Lasa M, Polevoda B, Gazquez C, Elosegui-Artola A, Kim DS, De Juan-Pardo E, Demeyer K, Hole K, Larrea E, Timmerman E, Prieto J, Arnesen T, Sherman F, Gevaert K, Aldabe R.

Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54. doi: 10.1073/pnas.1210303109. Epub 2012 Jul 18.

19.

Thyroid hormone antagonizes tumor necrosis factor-alpha signaling in pituitary cells through the induction of dual specificity phosphatase 1.

Lasa M, Gil-Araujo B, Palafox M, Aranda A.

Mol Endocrinol. 2010 Feb;24(2):412-22. doi: 10.1210/me.2009-0298. Epub 2009 Dec 23.

20.

Characterization of the human Nalpha-terminal acetyltransferase B enzymatic complex.

Ametzazurra A, Gázquez C, Lasa M, Larrea E, Prieto J, Aldabe R.

BMC Proc. 2009 Aug 4;3 Suppl 6:S4. doi: 10.1186/1753-6561-3-S6-S4.

21.

Thyroid hormone-mediated activation of the ERK/dual specificity phosphatase 1 pathway augments the apoptosis of GH4C1 cells by down-regulating nuclear factor-kappaB activity.

Chiloeches A, Sánchez-Pacheco A, Gil-Araujo B, Aranda A, Lasa M.

Mol Endocrinol. 2008 Nov;22(11):2466-80. doi: 10.1210/me.2008-0107. Epub 2008 Aug 28.

22.
23.

Low cell cholesterol levels increase NFkappaB activity through a p38 MAPK-dependent mechanism.

Calleros L, Lasa M, Toro MJ, Chiloeches A.

Cell Signal. 2006 Dec;18(12):2292-301. Epub 2006 Jun 27.

PMID:
16806824
24.

RhoA and p38 MAPK mediate apoptosis induced by cellular cholesterol depletion.

Calleros L, Lasa M, Rodríguez-Alvarez FJ, Toro MJ, Chiloeches A.

Apoptosis. 2006 Jul;11(7):1161-73.

PMID:
16699960
25.
26.

Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways.

Clark AR, Lasa M.

Curr Opin Pharmacol. 2003 Aug;3(4):404-11. Review.

PMID:
12901950
27.
28.

Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects.

Delzenne NM, Daubioul C, Neyrinck A, Lasa M, Taper HS.

Br J Nutr. 2002 May;87 Suppl 2:S255-9. Review.

PMID:
12088526
29.

Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38.

Lasa M, Brook M, Saklatvala J, Clark AR.

Mol Cell Biol. 2001 Feb;21(3):771-80.

30.

Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade.

Lasa M, Mahtani KR, Finch A, Brewer G, Saklatvala J, Clark AR.

Mol Cell Biol. 2000 Jun;20(12):4265-74.

31.

Phosphorylation of osteopontin by Golgi apparatus casein kinase.

Lasa M, Chang PL, Prince CW, Pinna LA.

Biochem Biophys Res Commun. 1997 Nov 26;240(3):602-5.

PMID:
9398611
32.

Evaluation of visual function following neodymium:YAG laser posterior capsulotomy.

Magno BV, Datiles MB, Lasa MS, Fajardo MR, Caruso RC, Kaiser-Kupfer MI.

Ophthalmology. 1997 Aug;104(8):1287-93.

PMID:
9261315
33.

Lovastatin decreases prolactin and growth hormone gene expression in GH4C1 cells through a cAMP dependent mechanism.

Lasa M, Chiloeches A, García N, Montes A, Toro MJ.

Mol Cell Endocrinol. 1997 Jun 20;130(1-2):93-100.

PMID:
9220025
34.
35.

Effect of mevalonate availability on the association of G-protein alpha-subunits with the plasma membrane in GH4C1 cells.

Chiloeches A, Usera F, Lasa M, Ropero S, Montes A, Toro MJ.

FEBS Lett. 1997 Jan 13;401(1):68-72.

36.

A longitudinal study of cortical cataracts using retroillumination photographs.

Datiles MB 3rd, Lasa MS, Freidlin V.

Curr Eye Res. 1996 Jan;15(1):53-61.

PMID:
8631204
37.

Lymphangiosarcoma in a chronic lymphedematous limb: a case report.

Lasa MV, Mateo P, Bascón N, Baquedano J, Fuertes F, López P, Escó R.

Tumori. 1995 Sep-Oct;81(5):381-2.

PMID:
8804458
38.

Potential vision tests in patients with cataracts.

Lasa MS, Datiles MB 3rd, Freidlin V.

Ophthalmology. 1995 Jul;102(7):1007-11.

PMID:
9121743
39.

Effects of lovastatin on adenylyl cyclase activity and G proteins in GH4C1 cells.

Chiloeches A, Lasa M, Brihuega F, Montes A, Toro MJ.

FEBS Lett. 1995 Mar 13;361(1):46-50.

40.

Scheimpflug photography and postcataract surgery posterior capsule opacification.

Lasa MS, Datiles MB 3rd, Magno BV, Mahurkar A.

Ophthalmic Surg. 1995 Mar-Apr;26(2):110-3.

PMID:
7596535
41.

Progression of lens opacities in cataract patients after one year.

Magno BV, Datiles MB, Lasa MS.

Acta Ophthalmol Scand. 1995 Feb;73(1):45-9.

PMID:
7627758
42.

Measurement error in assessing the size of cortical cataracts from retroillumination photographs.

Datiles MB, Lasa MS, Podgor MJ, Hernandez-Galilea E, Magno BV.

Curr Eye Res. 1995 Jan;14(1):19-26.

PMID:
7720402
43.

Comparison of linear, multilinear and mask microdensitometric analyses of Scheimpflug images of the lens nucleus.

Magno BV, Lasa MS, Freidlin V, Datiles MB.

Curr Eye Res. 1994 Nov;13(11):825-31.

PMID:
7851118
44.

Glare sensitivity in early cataracts.

Lasa MS, Podgor MJ, Datiles MB 3rd, Caruso RC, Magno BV.

Br J Ophthalmol. 1993 Aug;77(8):489-91.

45.

Cholesterol cell content affects prolactin but not growth hormone release in GH4C1 cells.

Lasa M, Perez-Caballero FJ, Usera F, Chiloeches A, Montes A, Toro MJ.

Endocrinology. 1993 Apr;132(4):1701-6.

PMID:
8462470
46.

Contrast and glare sensitivity. Association with the type and severity of the cataract.

Lasa MS, Datiles MB 3rd, Podgor MJ, Magno BV.

Ophthalmology. 1992 Jul;99(7):1045-9.

PMID:
1495782

Supplemental Content

Support Center